Order Article Reprints

Huang KC-Y, Chiang S-F, Yang P-C, Ke T-W, Chen T-W, Hu C-H, Huang Y-W, Chang H-Y, Chen WT-L, Chao KSC. Immunogenic Cell Death by the Novel Topoisomerase I Inhibitor TLC388 Enhances the Therapeutic Efficacy of Radiotherapy. Cancers. 2021; 13(6):1218. https://doi.org/10.3390/cancers13061218

Huang, Kevin Chih-Yang, Shu-Fen Chiang, Pei-Chen Yang, Tao-Wei Ke, Tsung-Wei Chen, Ching-Han Hu, Yi-Wen Huang, Hsin-Yu Chang, William Tzu-Liang Chen, and K. S. Clifford Chao. 2021. "Immunogenic Cell Death by the Novel Topoisomerase I Inhibitor TLC388 Enhances the Therapeutic Efficacy of Radiotherapy" Cancers 13, no. 6: 1218. https://doi.org/10.3390/cancers13061218

Huang, K. C.-Y., Chiang, S.-F., Yang, P.-C., Ke, T.-W., Chen, T.-W., Hu, C.-H., Huang, Y.-W., Chang, H.-Y., Chen, W. T.-L., & Chao, K. S. C. (2021). Immunogenic Cell Death by the Novel Topoisomerase I Inhibitor TLC388 Enhances the Therapeutic Efficacy of Radiotherapy. Cancers, 13(6), 1218. https://doi.org/10.3390/cancers13061218